Gain of 20q11.21 in human embryonic stem cells improves cell survival by increased expression of Bcl-xL

Molecular Human Reproduction

Volumn 20, Issue 2, 2014, Pages 168-177

  Nguyen, H T ^a   Geens, M ^a   Mertzanidou, A ^a   Jacobs, K ^a   Heirman, C ^a   Breckpot, K ^a   Spits, C ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

20q11.21; Bcl xL; BCL2L1; Human embryonic stem cells; ID1; Pluripotent stem cells

Indexed keywords

BCL2L1 PROTEIN; DNA METHYLTRANSFERASE 3B; INHIBITOR OF DIFFERENTIATION 1; KIF3B PROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 1825; MICRORNA 3193; MINOR HISTOCOMPATIBILITY ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN 13; PROTEIN BCL XL; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; AMPLICON; APOPTOSIS; ARTICLE; CELL INTERACTION; CELL SURVIVAL; CHROMOSOME 20Q; CHROMOSOME ABERRATION; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; ENDOPLASMIC RETICULUM; GAIN OF 20Q11.21; GENE DOSAGE; GENE EXPRESSION; GENE MUTATION; GENE SILENCING; HALF LIFE TIME; HUMAN; HUMAN CELL; IN VITRO STUDY; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSGENICS; UPREGULATION; WILD TYPE;

20Q11.21; BCL-XL; BCL2L1; HUMAN EMBRYONIC STEM CELLS; ID1; PLURIPOTENT STEM CELLS;

APOPTOSIS; BCL-X PROTEIN; CELL LINE; CELL SURVIVAL; CHROMOSOME DUPLICATION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 20; EMBRYONIC STEM CELLS; GENE EXPRESSION; GENE KNOCKOUT TECHNIQUES; GENETIC LOCI; HUMANS; PLURIPOTENT STEM CELLS; RNA, SMALL INTERFERING;

EID: 84892498732     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gat077     Document Type: Article

References (36)

1. Amps K, Andrews PW, Anyfantis G, Armstrong L, Avery S, Baharvand H, Baker J, Baker D, Munoz MB, Beil S et al. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol 2011;29: 1132-1144.
2. Bai H, Chen K, Gao Y-X, Arzigian M, Xie Y-L, Malcosky C, Yang Y-G, Wu W-S, Wang ZZ. Bcl-xL enhances single-cell survival and expansion of human embryonic stem cells without affecting self-renewal. Stem Cell Res 2011;8:26-37.
3. Beroukhim R, Mermel CH, Porter D, Wei G, Donovan J, Barretina J, Boehm JS, Urashima M, Henry KTM, Pinchback RM et al. The landscape of somatic copy-number alteration across human cancers. Nature 2010; 463:899-905.
4. Breckpot K, Escors D, Arce F, Lopes L, Karwacz K, Van Lint S, Keyaerts M, Collins M. HIV-1 Lentiviral vector immunogenicity is mediated by toll-like receptor 3 (TLR3) and TLR7. J Virology 2010;84:5627-5636.
5. Buysse K, Delle Chiaie B, Van Coster R, Loeys B, De Paepe A, Mortier G, Speleman F, Menten B. Challenges for CNV interpretation in clinical molecular karyotyping: lessons learned from a 1001 sample experience. Eur J Med Genet 2009;52:398-403.
6. De Luca M, Lavia P, Guarguaglini G. A functional interplay between Aurora-A, Plk1 and TPX2 at spindle poles: Plk1 controls centrosomal localization of Aurora-A and TPX2 spindle association. Cell Cycle 2006; 5:296-303.
7. Elliott AM, Elliott K a H. Kammesheidt A High resolution array-CGH characterization of human stem cells using a stem cell focused microarray. Mol Biotechnol 2010;46:234-242.
8. Geens M, Mateizel I, Sermon K,DeRyckeM, Spits C, Cauffman G, DevroeyP, Tournaye H, Liebaers I, Van de Velde H. Human embryonic stem cell lines derived from single blastomeres of two 4-cell stage embryos. Hum Reprod 2009;24:2709-2717.
9. Giubettini M, Asteriti IA1, Scrofani J, De Luca M, Lindon C, Lavia P, Guarguaglini G. Control of Aurora-A stability through interaction with TPX2. J Cell Sci 2010;124:113-122.
10. Goyvaerts C, De Groeve K, Dingemans J, Van Lint S, Robays L, Heirman C, Reiser J, Zhang X-Y, Thielemans K, De Baetselier P et al. Development of the Nanobody display technology to target lentiviral vectors to antigen-presenting cells. Gene Therapy 2012;19:1133-1140.
11. Hong S-H, Lee J-H, Lee JB, Ji J, Bhatia M. ID1 and ID3 represent conserved negative regulators of human embryonic and induced pluripotent stem cell hematopoiesis. J Cell Sci 2011;124:1445-1452.
12. Kim H, Chung H, Kim H-J, Lee J-Y, Oh M-Y, Kim Y, Kong G. Id-1 regulates Bcl-2 and Bax expression through p53 and NF-kappaB in MCF-7 breast cancer cells. Breast Cancer Res Treat 2008;112:287-296.
13. Laurent LC, Ulitsky I, Slavin I, Tran H, Schork A, Morey R, Lynch C, Harness JV, Lee S, Barrero MJ et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 2011; 8:106-118.
14. Lefort N, Feyeux M, Bas C, Féraud O, Bennaceur-Griscelli A, Tachdjian G, Peschanski M, Perrier AL. Human embryonic stem cells reveal recurrent genomic instability at 20q11.21. Nat Biotechnol 2008;26:1364-1366.
15. Ling M-T, Wang X, Ouyang X-S, Xu K, Tsao S-W, Wong Y-C. Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells. Oncogene 2003;22:4498-4508.
16. Lund RJ, Närvä E, Lahesmaa R. Genetic and epigenetic stability of human pluripotent stem cells. Nature Reviews. Genetics 2012;13:732-744.
17. Martins-Taylor K, Nisler B, Taapken S, Compton T, Crandall L, Montgomery K, Lalande M, Xu R. Recurrent copy number variations in human induced pluripotent stem cells. Nat Biotechnol 2011;29:6-9.
18. Mateizel I, De Temmerman N, Ullmann U, Cauffman G, Sermon K, Van de Velde H, De Rycke M, Degreef E, Devroey P, Liebaers I et al. Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders. Hum Reprod 2006;21:503-511.
19. Mateizel I, Spits C,DeRyckeM, Liebaers I, Sermon K. Derivation, culture, and characterization of VUB hESC lines. In Vitro Cell Dev Biol Anim 2010; 46:300-308.
20. Meng Z, Lou S,Tan J,XuK, Jia Q, ZhengW. Nuclear factor-kappa B inhibition can enhance apoptosis of differentiated thyroid cancer cells induced by 131I. PloS one 2012;7:e33597.
21. Närvä E, Autio R, Rahkonen N, Kong L, Harrison N, Kitsberg D, Borghese L, Itskovitz-Eldor J, Rasool O,DvorakP et al. High-resolutionDNAanalysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat Biotechnol 2010;28:371-377.
22. Nguyen HT, Geens M, Spits C. Genetic and epigenetic instability in human pluripotent stem cells. Hum Reprod Update 2012;19:187-205.
23. Ohgushi M, Matsumura M, Eiraku M, Murakami K, Aramaki T, Nishiyama A, Muguruma K, Nakano T, Suga H, UenoMet al. Molecular pathway and cell state responsible for dissociation-induced apoptosis in human pluripotent stem cells. Cell Stem Cell 2010;7:225-239.
24. Rao PH, Houldsworth J, Palanisamy N, Murty VV, Reuter VE, Motzer RJ, Bosl GJ. Chromosomal amplification is associated with cisplatin resistance of human male germ cell tumors. Cancer Res 1998;58:4260-4263.
25. Romero-Lanman EE, Pavlovic S, Amlani B, Chin Y, Benezra R. Id1 maintains embryonic stem cell self-renewal by up-regulation of Nanog and repression of Brachyury expression. Stem Cells Dev 2012;21:384-393.
26. Scotto L, Narayan G, Nandula SV, Arias-pulido H, Subramaniyam S, Schneider A, Kaufmann AM, Wright JD, Pothuri B, Mansukhani M et al. Identification of Copy Number Gain and Overexpressed Genes on Chromosome Arm 20q by an Integrative Genomic Approach in Cervical Cancer: Potential Role in Progression. Gene Chromosome Cancer 2008; 47:755-765.
27. Sillars-Hardebol AH, Carvalho B, De Wit M, Postma C, Delis-van Diemen PM, Mongera S, Ylstra B, Van de Wiel MA, Meijer GA, Fijneman RJ. Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progression. Tumor Biol 2010;31:89-96.
28. Sillars-Hardebol AH,Carvalho B, Beliën JA,DeWitM, Delis-van Diemen PM, Tijssen M, Van deWiel MA, Pontén F, Fijneman RJ, Meijer GA. BCL2L1 has a functional role in colorectal cancer and its protein expression is associated with chromosome 20q gain. J Pathol 2011;1:7-10.
29. Smith LT, Mayerson J, Nowak NJ, Suster D, Mohammed N, Long S, Auer H, Jones S, McKeegan C, Young G et al. 20q11.1 amplification in giant-cell tumor of bone: array CGH, FISH, and association with outcome. Genes Chromosome Cancer 2006;45:957-966.
30. Spits C, Mateizel I, Geens M, Mertzanidou A, Staessen C,VandeskeldeY,Van der Elst J, Liebaers I, Sermon K. Recurrent chromosomal abnormalities in human embryonic stem cells. Nat Biotechnol 2008;26:1361-1363.
31. Tabach Y, Kogan-Sakin I, Buganim Y, Solomon H, Goldfinger N, Hovland R, Ke X-S, Oyan AM, Kalland K-H, Rotter V et al. Amplification of the 20q chromosomal arm occurs early in tumorigenic transformation and may initiate cancer. PloS One 2011;6:e14632.
32. Tonon G, Wong KK, Maulik G, Brennan C, Feng B, Zhang Y, Khatry DB, Protopopov A, You MJ, Aguirre AJ et al. High-resolution genomic profiles of human lung cancer. PNAS 2006;102:9625-9630.
33. Werbowetski-Ogilvie TE, Bossé M, Stewart M, Schnerch A, Ramos-Mejia V, Rouleau A, Wynder T, Smith M-J, Dingwall S, Carter T et al. Characterization of human embryonic stem cells with features of neoplastic progression. Nat Biotechnol 2009;27:91-97.
34. Werbowetski-Ogilvie TE, Morrison LC, Fiebig-Comyn A, Bhatia M. In Vivo generation of neural tumors from neoplastic pluripotent stem cells models early human pediatric brain tumor formation. Stem Cell 2012; 30:392-404.
35. WuH, Kim KJ, Mehta K, Paxia S, SundstromA, Anantharaman T, Kuraishy AI, Doan T, Ghosh J, Pyle AD et al. Copy number variant analysis of human embryonic stem cells. Stem Cells 2008;26:1484-1489.
36. Yang S, Lin G, Tan Y, Zhou D, Deng L, Cheng D, Luo S, Liu T, Zhou X, Sun Z et al. Tumor progression of culture-adapted human embryonic stem cells during long-term culture. Gene Chromosome Canc 2008;47:665-679.